Article
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
Cancer research - 15 Mar 2009
Schildkraut Joellen M, Goode Ellen L, Clyde Merlise A, Iversen Edwin S, Moorman Patricia G, Berchuck Andrew, Marks Jeffrey R, Lissowska Jolanta, Brinton Louise, Peplonska Beata, Cunningham Julie M, Vierkant Robert A, Rider David N, Chenevix-Trench Georgia, Webb Penelope M, Beesley Jonathan, Chen Xiaoqing, Phelan Catherine, Sutphen Rebecca, Sellers Thomas A, Pearce Leigh, Wu Anna H, Van Den Berg David, Conti David, Elund Christopher K, Anderson Rebecca, Goodman Marc T, Lurie Galina, Carney Michael E, Thompson Pamela J, Gayther Simon A, Ramus Susan J, Jacobs Ian, Krüger Kjaer Susanne, Hogdall Estrid, Blaakaer Jan, Hogdall Claus, Easton Douglas F, Song Honglin, Pharoah Paul D P, Whittemore Alice S, McGuire Valerie, Quaye Lydia, Anton-Culver Hoda, Ziogas Argyrios, Terry Kathryn L, Cramer Daniel W, Hankinson Susan E, Tworoger Shelley S, Calingaert Brian, Chanock Stephen, Sherman Mark, Garcia-Closas Montserrat
Abstract excerpt
The p53 protein is critical for multiple cellular functions including cell growth and DNA repair. We assessed whether polymorphisms in the region encoding TP53 were associated with risk of invasive ovarian cancer. The study population includes a total of 5,206 invasive ovarian cancer cases (2,829 of which were serous) and 8,790 controls from 13 case-control or nested case-control studies participating in the...
Read the complete abstract on PubMed